NCT03495817View on ClinicalTrials.gov

A Study in Male and Female Subjects With Androgenetic Alopecia Treated With ATI-50002 Topical Solution

PHASE2CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

March 22, 2018

Primary Completion Date

October 15, 2019

Study Completion Date

October 30, 2019

Conditions
Androgenetic Alopecia
Interventions
DRUG

ATI-50002

ATI-50002 Topical Solution

Trial Locations (3)

78759

Aclaris Investigational Site, Austin

80210

Aclaris Investigational Site, Denver

97210

Aclaris Investigational Site, Portland

Sponsors
All Listed Sponsors
lead

Aclaris Therapeutics, Inc.

INDUSTRY

NCT03495817 - A Study in Male and Female Subjects With Androgenetic Alopecia Treated With ATI-50002 Topical Solution | Biotech Hunter | Biotech Hunter